Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance

Citations Over TimeTop 10% of 2022 papers

Abstract

All aspects of prostate cancer evolution are closely related to androgen levels and the status of the androgen receptor (AR). Almost all treatments target androgen metabolism pathways and AR, from castration-sensitive prostate cancer (CSPC) to castration-resistant prostate cancer (CRPC). Alterations in androgen metabolism and its response are one of the main reasons for prostate cancer drug resistance. In this review, we will introduce androgen metabolism, including how the androgen was synthesized, consumed, and responded to in healthy people and prostate cancer patients, and discuss how these alterations in androgen metabolism contribute to the resistance to anti-androgen therapy.

Related Papers

• → Are androgen receptor variants a substitute for the full-length receptor?(2015)124 cited
• → Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer(2014)35 cited
• → PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells(2020)15 cited
• → Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer(2023)5 cited
• → Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives(2017)25 cited